High-performance liquid chromatographic assay with ultraviolet detection for quantification of dihydrofluorouracil in human lymphocytes: application to measurement of dihydropyrimidine dehydrogenase activity |
| |
| Authors: | R Dporte-Fty M Picot M Amiand A Moreau L Campion D Lanoë N Rene G Milano |
| |
| Institution: | a Laboratoire de Pharmacocinétique, Centre Renée Gauducheau, Boulevard Jacques Monod, Saint Herblain Cedex, France;b Laboratoire d’Oncopharmacologie, Centre Antoine Lacassagne, Nice, France |
| |
| Abstract: | The anticancer drug 5-fluorouracil (5FU) undergoes extensive biotransformation to 5-dihydrofluorouracil (5FUH2) by the enzyme dihydropyrimidine deshydrogenase (DPD). A new HPLC method with direct UV detection for the determination of 5FUH2 in peripheral lymphocytes has been developed to detect DPD deficiency in patients treated with 5FU-based therapy. The method has been shown to be valid over the 5FUH2 concentration range of 1.14–37.88 nmol/ml. Optimal enzymatic conditions for DPD activity measurement were studied: incubation time, protein and 5FU concentrations. The assay was successfully cross-validated with the existing method using HPLC with radiochemical detection. |
| |
| Keywords: | Dihydrofluorouracil Dihydropyrimidine dehydrogenase Enzymes |
| 本文献已被 ScienceDirect 等数据库收录！ |
